Skip to Main Content

Paper Details

Efficacy and pharmacokinetic/pharmacodynamic evaluation of the Aurora kinase A inhibitor MLN8237 against preclinical models of pediatric cancer.
Cancer Chemother Pharmacol
75
2011
ALL, ALL models, ALL xenografts, AURKA, Aurora kinase A, Ewing sarcoma, Ewing sarcoma lines, MLN8237, childhood cancer, neuroblastoma, neuroblastoma and Ewing sarcoma, neuroblastoma and Ewing sarcoma cell lines, neuroblastoma cell lines, pediatric cancer, pediatric malignancies, solid tumor, tumors, xenografts

Datasets

Release 1.2